Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Neurology
|
October 29, 2014
Disparities in deep brain stimulation surgery among insured elders with Parkinson disease
Matthew Barrett, Guofen Yan, Robert D Abbott, et al.
European Heart Journal. Case Reports
|
June 8, 2026
Beyond the gut: a case report of <i>Shigella</i>-associated myocarditis
Liam Maher, David Murphy, Tara Ramsbottom, et al.
Biochemistry
|
June 19, 2012
Fluorescent phosphatidylinositol 4,5-bisphosphate derivatives with modified 6-hydroxy group as novel substrates for phospholipase C
Xiaoyang Wang, Matthew Barrett, John Sondek, et al.
JSES International
|
December 21, 2020
Larger polyethylene glenospheres in reverse shoulder arthroplasty: are they safe?
Carl W Jones, Matthew Barrett, John Erickson, et al.
JACC. Basic to Translational Science
|
September 1, 2021
Cardio-Oncology: Understanding the Intersections Between Cardiac Metabolism and Cancer Biology
Anja Karlstaedt, Matthew Barrett, Ray Hu, et al.
ESC Heart Failure
|
August 28, 2025
A prospective analysis of management and outcomes of worsening heart failure in the outpatient setting
Joseph McCambridge, Fiyinfoluwa Fabamwo, Shadia Taha, et al.
Research Square
|
November 28, 2024
Parkinson's Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype?
Ahmed Negida, Hiba Vohra, Sarah Lageman, et al.
Biomedical Microdevices
|
August 10, 2014
A miniature quantitative PCR device for directly monitoring a sample processing on a microfluidic rapid DNA system
Cedric Hurth, Jianing Yang, Matthew Barrett, et al.
European Journal of Heart Failure
|
November 4, 2024
The daily challenges to patients posed by diuretic therapy: What they are and what do patients do?
Giulia Bruno, Matthew Barrett, Emma Brennan, et al.
International Journal of Heart Failure
|
October 20, 2022
Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?
Brian Kerr, Rebabonye B Pharithi, Matthew Barrett, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Neurology
|
October 29, 2014
Disparities in deep brain stimulation surgery among insured elders with Parkinson disease
Matthew Barrett, Guofen Yan, Robert D Abbott, et al.
European Heart Journal. Case Reports
|
June 8, 2026
Beyond the gut: a case report of <i>Shigella</i>-associated myocarditis
Liam Maher, David Murphy, Tara Ramsbottom, et al.
Biochemistry
|
June 19, 2012
Fluorescent phosphatidylinositol 4,5-bisphosphate derivatives with modified 6-hydroxy group as novel substrates for phospholipase C
Xiaoyang Wang, Matthew Barrett, John Sondek, et al.
JSES International
|
December 21, 2020
Larger polyethylene glenospheres in reverse shoulder arthroplasty: are they safe?
Carl W Jones, Matthew Barrett, John Erickson, et al.
JACC. Basic to Translational Science
|
September 1, 2021
Cardio-Oncology: Understanding the Intersections Between Cardiac Metabolism and Cancer Biology
Anja Karlstaedt, Matthew Barrett, Ray Hu, et al.
ESC Heart Failure
|
August 28, 2025
A prospective analysis of management and outcomes of worsening heart failure in the outpatient setting
Joseph McCambridge, Fiyinfoluwa Fabamwo, Shadia Taha, et al.
Research Square
|
November 28, 2024
Parkinson's Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype?
Ahmed Negida, Hiba Vohra, Sarah Lageman, et al.
Biomedical Microdevices
|
August 10, 2014
A miniature quantitative PCR device for directly monitoring a sample processing on a microfluidic rapid DNA system
Cedric Hurth, Jianing Yang, Matthew Barrett, et al.
European Journal of Heart Failure
|
November 4, 2024
The daily challenges to patients posed by diuretic therapy: What they are and what do patients do?
Giulia Bruno, Matthew Barrett, Emma Brennan, et al.
International Journal of Heart Failure
|
October 20, 2022
Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?
Brian Kerr, Rebabonye B Pharithi, Matthew Barrett, et al.
Page
of 6